AAAAAA

   
Results: 1-8 |
Results: 8
IN-VITRO CYTOKINE PROFILES AS INDICATORS OF RELAPSE ACTIVITY AND CLINICAL COURSE IN MULTIPLE-SCLEROSIS
Authors: SCHLUEP M VANMELLE G HENRY H STADLER C ROTHWICKY B MAGISTRETTI PJ
Citation: M. Schluep et al., IN-VITRO CYTOKINE PROFILES AS INDICATORS OF RELAPSE ACTIVITY AND CLINICAL COURSE IN MULTIPLE-SCLEROSIS, Multiple sclerosis, 4(3), 1998, pp. 198-202
EMERGING TREATMENTS IN MULTIPLE-SCLEROSIS
Authors: SCHLUEP M BOGOUSSLAVSKY J
Citation: M. Schluep et J. Bogousslavsky, EMERGING TREATMENTS IN MULTIPLE-SCLEROSIS, European neurology, 38(3), 1997, pp. 216-221
INTRATHECAL DELIVERY OF CNTF USING ENCAPSULATED GENETICALLY-MODIFIED XENOGENEIC CELLS IN AMYOTROPHIC-LATERAL-SCLEROSIS PATIENTS (VOL 2, PG 696, 1996)
Authors: AEBISCHER P SCHLUEP M DEGLON N JOSEPH JM HIRT L HEYD B GODDARD M HAMMANG JP ZURN AD KATO AC REGLI F BAETGE EE
Citation: P. Aebischer et al., INTRATHECAL DELIVERY OF CNTF USING ENCAPSULATED GENETICALLY-MODIFIED XENOGENEIC CELLS IN AMYOTROPHIC-LATERAL-SCLEROSIS PATIENTS (VOL 2, PG 696, 1996), Nature medicine, 2(9), 1996, pp. 1041-1041
INTRATHECAL DELIVERY OF CNTF USING ENCAPSULATED GENETICALLY-MODIFIED XENOGENEIC CELLS IN AMYOTROPHIC-LATERAL-SCLEROSIS PATIENTS
Authors: AEBISCHER P SCHLUEP M DEGLON N JOSEPH JM HIRT L HEYD B GODDARD M HAMMANG JP ZURN AD KATO AC REGLI F BAETGE EE
Citation: P. Aebischer et al., INTRATHECAL DELIVERY OF CNTF USING ENCAPSULATED GENETICALLY-MODIFIED XENOGENEIC CELLS IN AMYOTROPHIC-LATERAL-SCLEROSIS PATIENTS, Nature medicine, 2(6), 1996, pp. 696-699
GENE-THERAPY FOR AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) USING A POLYMER ENCAPSULATED XENOGENIC CELL-LINE ENGINEERED TO SECRETE HCNTF
Authors: AEBISCHER P POCHON NAM HEYD B DEGLON N JOSEPH JM ZURN AD BAETGE EE HAMMANG JP GODDARD M LYSAGHT M KAPLAN F KATO AC SCHLUEP M HIRT L REGLI F PORCHET F DETRIBOLET N
Citation: P. Aebischer et al., GENE-THERAPY FOR AMYOTROPHIC-LATERAL-SCLEROSIS (ALS) USING A POLYMER ENCAPSULATED XENOGENIC CELL-LINE ENGINEERED TO SECRETE HCNTF, Human gene therapy, 7(7), 1996, pp. 851-860
JUSTIFICATION OF HOSPITAL DAYS AND DISCHARGE DELAYS IN A NONSELECTED POPULATION OF ACUTE STROKE PATIENTS
Authors: VUADENS P SCHLUEP M BOGOUSSLAVSKY J REGLI F
Citation: P. Vuadens et al., JUSTIFICATION OF HOSPITAL DAYS AND DISCHARGE DELAYS IN A NONSELECTED POPULATION OF ACUTE STROKE PATIENTS, Journal of the neurological sciences, 143(1-2), 1996, pp. 132-136
JUSTIFICATION OF HOSPITAL DAYS AND EPIDEMIOLOGY OF DISCHARGE DELAYS IN A DEPARTMENT OF NEUROLOGY
Authors: SCHLUEP M BOGOUSSLAVSKY J REGLI F TENDON M PRODHOM LS KLEIBER C
Citation: M. Schluep et al., JUSTIFICATION OF HOSPITAL DAYS AND EPIDEMIOLOGY OF DISCHARGE DELAYS IN A DEPARTMENT OF NEUROLOGY, Neuroepidemiology, 13(1-2), 1994, pp. 40-49
CEREBROSPINAL-FLUID IN THE DIAGNOSIS OF MULTIPLE-SCLEROSIS - A CONSENSUS REPORT
Authors: ANDERSSON M ALVAREZCERMENO J BERNARDI G COGATO I FREDMAN P FREDERIKSEN J FREDRIKSON S GALLO P GRIMALDI LM GRONNING M KEIR G LAMERS K LINK H MAGALHAES A MASSARO AR OHMAN S REIBER H RONNBACK L SCHLUEP M SCHULLER E SINDIC CJM THOMPSON EJ TROJANO M WURSTER U
Citation: M. Andersson et al., CEREBROSPINAL-FLUID IN THE DIAGNOSIS OF MULTIPLE-SCLEROSIS - A CONSENSUS REPORT, Journal of Neurology, Neurosurgery and Psychiatry, 57(8), 1994, pp. 897-902
Risultati: 1-8 |